0001076930 2026-07-22 2026-07-22 0001076930 novt:SixPointFiveZeroPercentTangibleEquityUnitsMember 2026-07-22 2026-07-22 0001076930 us-gaap:CommonStockMember 2026-07-22 2026-07-22 0001076930 true 8-K/A 2026-07-22 NOVANTA INC. A3 001-35083 98-0110412 125 Middlesex Turnpike Bedford MA 01730 781 266-5700 false false false false Common shares, no par value NOVT NASDAQ 6.50% Tangible Equity Units NOVTU NASDAQ false As previously disclosed by Novanta Inc., a New Brunswick corporation (the “Company”) in the Current Report on Form 8-K filed on June 9, 2026 (the “Previous Form 8-K”) with the Securities and Exchange Commission, on June 8, 2026, the Company, Novanta Medical Technologies Corp., a Delaware corporation and an indirect subsidiary of the Company (“Buyer”), Novanta Corporation, a Michigan corporation (“Intermediate Parent”, and together with the Company and the Buyer, the “Buyer Parties”), Runway Midco, LLC, a Delaware limited liability company (“Seller”), and Runway Buyer, LLC, a Delaware limited liability company and direct wholly owned subsidiary of Seller (“Runway Buyer”), entered into an Equity Purchase Agreement (the “Purchase Agreement”), pursuant to which Buyer agreed to acquire from Seller all of the issued and outstanding limited liability company interests (the “Purchased Interests”) of Runway Buyer (the “Transaction”).  On July 23, 2026, the closing of the Transaction (the “Closing”) occurred.  This Current Report on Form 8-K/A is filed as an amendment to the Current Report on Form 8-K filed by the Company on July 27, 2026, pursuant to Item 9.01(a)(3) and (b)(2) of Form 8-K, to include the financial information required pursuant to Item 9.01(a) and (b) of Form 8-K.